![Trevor Biden [C]](https://images.contentstack.io/v3/assets/blt324fd0a04af716e6/bltf924644ec09a1ae7/64c79e914c154e3104900baa/C500366-trevor_biden_[c].jpg?fit=crop&width=178&height=208)
Professor Trevor Biden
Professor Trevor Biden first studied an undergraduate degree in Biochemistry at the University, then undertaking his PhD with Keith Taylor at London Hospital Medical College. He subsequently worked as a post-doc during a very productive era in Claes Wollheim’s lab in Geneva. Following a short sojourn at the Australian National University in Canberra, Trevor commenced his own independent lab at the Garvan Institute of Medical Research. Over time he has trained many PhDs and post-docs, some of whom now head their own closely aligned labs within Garvan.
Trevor has a long-standing international reputation in the area of basic beta cell biology. He has made important contributions in the areas of regulating insulin secretion and beta cell apoptosis, and his work straddles both T1D and T2D. In recent years he has been instrumental in elucidating and characterising the contribution of ER stress to beta cell dysregulation. He is now extending his research focus more broadly in beta cell biology to encompass studies in autophagy and lysosomal biology, as well as inflammation.
He holds several patents, has worked closely with several pharmaceutical/biotech companies, and has served on the Editorial Advisory Board or as Associate Editor for the two leading journals in diabetes field, Diabetes and Diabetologia. He has made an extensive and ongoing contribution to grant review panels with both JDRFI and NHMRC.